ABSTRACT
Purpose To detect the expression of N-Myc and p53 in the tissues of prostate cancer (PCa) patients and to explore the relationship between them and their significance.Methods A total of 63 patients with PCa and 50 patients with benign prostatic hyperplasia (BPH) who underwent prostate surgery at the First Affiliated Hospital of Anhui Medical University were recruited in 2015-2016. The expression of N-Myc and p53 in pathological tissues were detected by immunohistochemistry of MaxVision method. Results The expression of N-Myc and p53 in PCa tissues was increased (P < 0.05). The expression of N-Myc and p53 in PCa tissues was correlated with bone metastases and TNM stage (P < 0.05), but not related to patient age, preoperative PSA level and other factors (P> 0.05). In addition, the expression of p53 was also correlated with Gleason score.Conclusion The high expression of N-Myc and p53 in PCa may involved in the malignant progression and metastasis of prostate cancer, and it is expected to become a new target for detecting PCa metastasis.
ABSTRACT
Purpose To detect the expression of miR-421 in serum and tissues of prostate cancer ( PCa) and its clinical value inPCa. Methods 62 cases of PCa and 46 cases of benign prostatic hyperplasia (BPH) were enrolled in the Department of Urology, the First Affiliated Hospital of Anhui Medical Universi-ty from December 2015 to December 2016. Another 42 cases of paraffin-embedded sections of PCa and 37 cases of BPH were al-so used in this study. The expression of miR-421 in serum was detected by real-time PCR (qRT-PCR). The expression of miR-421 in tissues was detected by in situ hybridization. Results The expression of miR-421 in serum of patients with PCa and BPH was ( 2. 52 ± 1. 70 ) and ( 0. 82 ± 0. 65 ), respectively. Compared with the expression of BPH, the expression of miR- 421 in serum of PCa was increased (P＜0. 05). The expression of miR-421 in serum and tissues of patients with PCa was corre-lated with Gleason score, TNM clinical stage, and bone metasta-ses (P＜0. 05). It was not related to the patient's age, preop-erative PSA level and other factors ( P＞0. 05). Conclusion miR-421 is more abundant in PCa patients than that in patients with benign prostatic hyperplasia, and is expected to become a diagnostic marker for PCa.
ABSTRACT
<p><b>OBJECTIVE</b>To examine and follow up cervical cytology of pregnant and postpartum women and study their cytopathologic characteristics, so as to determine screening and managing programs for abnormal cervical cytology.</p><p><b>METHODS</b>Totally 5296 patients in pregnancy and postpartum, in which 3729 by computer-assisted cytology test and 1567 by liquid-based monolayers cytology test, were examined and diagnosed by the Bethesda System made in 2001. Those proven epithelial abnormalities patients were followed up until the lesions regressed to normal. The remaining patients, who exhibited persistent abnormalities or progression, were given further examinations.</p><p><b>RESULTS</b>The positive rate of cervical cytological test was 8.72% (462/5296), including squamous carcinoma (SCA) 1 case (0.02%), high grade squamous intraepithelial lesion (HSIL) 34 cases (0.64%), low grade squamous intraepithelial lesion (LSIL) 145 cases (2.74%), atypical glandular cells (AGC) 5 cases (0.09%), atypical squamous cells cannot exclude HSIL (ASC-H) 14 cases (0.26%), atypical squamous cells of undetermined significance (ASC-US) 263 cases (4.97%). The 419 proven cytological abnormality cases were followed up successfully. The total transnegative rate in three months was 73.74% (309/419), in which 303 cases (72.32%) persisted normal status for more than six months after regression. And the transnegative rate of ASC-US, ASC-H, AGC, LSIL, and HSIL were 79.56%, 64.29%, 100%, 72.14% and 44.12%, respectively. Forty-six cases received biopsy directed by colposcopy. The distribution of coincidence of cytopathologic and histopathologic diagnosis was: SCA 1 case (100%), HSIL 10 cases (76.92%), LSIL 13 cases (65%), ASC-H 2 cases (50%), ASC-US 3 cases (37.50%), total 29 cases (63.04%).</p><p><b>CONCLUSIONS</b>We should cast more attention to screening cervix lesions in pregnant and postpartum women. Their cytopathologic characteristics are liable to make the clinician give a false positive diagnosis. So we propose to follow up them closely and to lower the indication of biopsy.</p>